Sun-Novo(SH:688621)2022-10-24 16:00Financial Performance - The company's revenue for Q3 2022 reached ¥170,931,848.01, representing a year-over-year increase of 46.12%[10] - Net profit attributable to shareholders for Q3 2022 was ¥41,522,105.64, up 58.68% compared to the same period last year[10] - The net profit attributable to shareholders after deducting non-recurring gains and losses for Q3 2022 was ¥38,806,994.17, reflecting a 48.33% increase year-over-year[10] - Basic earnings per share for Q3 2022 were ¥0.52, up 57.58% year-over-year[12] - Total revenue for the first three quarters of 2022 reached ¥495,240,315.22, a significant increase from ¥341,097,584.39 in the same period of 2021, representing an increase of approximately 45.2%[40] - Operating profit for the first three quarters of 2022 was ¥138,459,567.13, up from ¥99,819,540.64 in 2021, reflecting a growth of approximately 38.7%[43] - The total profit for the period reached ¥138,280,701.76, an increase from ¥99,589,235.79 in the previous year, representing a growth of approximately 38.8%[47] - Net profit attributable to shareholders of the parent company was ¥128,904,629.15, up from ¥85,132,224.00, marking a year-over-year increase of about 51.4%[49] - Basic and diluted earnings per share were both ¥1.61, compared to ¥1.42 in the same period last year, reflecting an increase of 13.4%[49] Research and Development - R&D investment totaled ¥20,570,732.16 in Q3 2022, accounting for 12.03% of revenue, a decrease of 1.56 percentage points from the previous year[12] - R&D investment for the year-to-date reached ¥56,698,742.50, reflecting a 58.92% increase compared to the previous year[12] - The company has invested significantly in R&D, with R&D expenses reaching ¥56,698,742.50, up from ¥35,676,542.07, indicating a focus on innovation and product development[43] Assets and Liabilities - The total assets of the company at the end of Q3 2022 were ¥1,361,723,218.02, an increase of 9.58% compared to the end of the previous year[12] - Non-current assets totaled ¥383,753,884.31, an increase from ¥300,865,652.43 year-over-year, marking a growth of about 27.5%[40] - Total assets amounted to ¥1,361,723,218.02, compared to ¥1,242,650,859.02 in the previous year, representing an increase of approximately 9.6%[40] - Current liabilities increased to ¥440,028,970.00 from ¥417,825,548.02, showing a rise of about 5.0%[40] Cash Flow and Liquidity - The company reported a net cash flow from operating activities of ¥8,031,810.43 for the year-to-date, a significant decrease of 82.38% compared to the previous year[12] - Cash flow from operating activities amounted to ¥8,031,810.43, a decrease from ¥45,583,455.19 in the previous year[52] - Cash and cash equivalents at the end of the period totaled ¥559,003,256.01, compared to ¥271,282,400.47 at the end of the same period last year, indicating a significant increase of 106.6%[53] - The company's cash and cash equivalents as of September 30, 2022, amount to ¥559,003,256.01, an increase from ¥490,251,185.19 at the end of 2021[35] - The company reported cash inflow from investment activities of ¥137,226,019.65, compared to ¥809,869.59 in the previous year, showing a substantial increase[52] - The company recorded cash outflow from financing activities of ¥111,620,050.83, compared to ¥31,421,781.69 in the previous year, indicating increased financing activities[52] Shareholder Information - The total number of common shareholders at the end of the reporting period is 5,004, with the largest shareholder holding 27.59% of shares[24] - Liu Yujing, a natural person, holds 4,333,701 shares, representing 5.42% of the total shares, with 2,000,000 shares pledged[24] - The top ten shareholders hold a significant portion of the company's shares, with the top three alone accounting for over 36%[24] - The total number of shares held by the top ten unrestricted shareholders is 16,000,000, indicating a concentrated ownership structure[28] Strategic Outlook - The company attributed the revenue growth to strengthened market expansion and the operational efficiency improvements from new laboratory setups[18] - The company plans to continue expanding its market presence and investing in new product development to drive future growth[48]